These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
494 related articles for article (PubMed ID: 26789102)
1. Long-term side effects of glucocorticoids. Oray M; Abu Samra K; Ebrahimiadib N; Meese H; Foster CS Expert Opin Drug Saf; 2016; 15(4):457-65. PubMed ID: 26789102 [TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid therapy for gastrointestinal diseases. Triadafilopoulos G Expert Opin Drug Saf; 2014 May; 13(5):563-72. PubMed ID: 24742121 [TBL] [Abstract][Full Text] [Related]
3. [Long-term glucocorticoid therapy : Is there a safe dosage?]. Strehl C; Buttgereit F Internist (Berl); 2016 Sep; 57(9):934-9. PubMed ID: 27351788 [TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid safety for treating rheumatoid arthritis. Rasch LA; Bultink IE; van Tuyl LH; Lems WF Expert Opin Drug Saf; 2015 Jun; 14(6):839-44. PubMed ID: 25802019 [TBL] [Abstract][Full Text] [Related]
5. Prevention and treatment of systemic glucocorticoid side effects. Moghadam-Kia S; Werth VP Int J Dermatol; 2010 Mar; 49(3):239-48. PubMed ID: 20465658 [TBL] [Abstract][Full Text] [Related]
6. The epidemiology of glucocorticoid-associated adverse events. McDonough AK; Curtis JR; Saag KG Curr Opin Rheumatol; 2008 Mar; 20(2):131-7. PubMed ID: 18349741 [TBL] [Abstract][Full Text] [Related]
7. An overview of the adverse reactions to adrenal corticosteroids. Frauman AG Adverse Drug React Toxicol Rev; 1996 Nov; 15(4):203-6. PubMed ID: 9113247 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of the respiratory distress syndrome in newborns: smoothened agonist counterbalances deleterious effects of glucocorticoids]. Griveau A Med Sci (Paris); 2012 Feb; 28(2):141-3. PubMed ID: 22377298 [No Abstract] [Full Text] [Related]
9. Systemic glucocorticoids: important issues and practical guidelines for the dermatologist. Dodiuk-Gad RP; Ish-Shalom S; Shear NH Int J Dermatol; 2015 Jun; 54(6):723-9. PubMed ID: 25683616 [TBL] [Abstract][Full Text] [Related]
10. Safety of inhaled corticosteroids for treating chronic obstructive pulmonary disease. Matera MG; Cardaci V; Cazzola M; Rogliani P Expert Opin Drug Saf; 2015 Apr; 14(4):533-41. PubMed ID: 25557156 [TBL] [Abstract][Full Text] [Related]
11. Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy: a questionnaire survey among members of the European Thyroid Association. Marcocci C; Watt T; Altea MA; Rasmussen AK; Feldt-Rasmussen U; Orgiazzi J; Bartalena L; Eur J Endocrinol; 2012 Feb; 166(2):247-53. PubMed ID: 22058081 [TBL] [Abstract][Full Text] [Related]
12. Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index. Schäcke H; Berger M; Rehwinkel H; Asadullah K Mol Cell Endocrinol; 2007 Sep; 275(1-2):109-17. PubMed ID: 17630119 [TBL] [Abstract][Full Text] [Related]
13. Medical management of inflammatory bowel disease in the elderly: balancing safety and efficacy. Ha CY Clin Geriatr Med; 2014 Feb; 30(1):67-78. PubMed ID: 24267603 [TBL] [Abstract][Full Text] [Related]